Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesDRI Healthcare Trust

DRI Healthcare Trust

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
13.9 CAD 0.91 ( 7.01%)
Last update at 2026-09-25T13:30:00Z
VOLUME
165
Market Cap
530.52M
P/E
5.85

Momentum Score

…

DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
13.90
Low
13.90
High
52 Week Price Range
4.45
Low
9.61
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on DRI Healthcare Trust (DHT‑U.TO) is limited, but the entity is listed as a trust focused on healthcare-related real estate in Canada. Long-term growth drivers could include an aging population, steady demand for medical and senior-care facilities, and the defensive rental cash flows such properties may generate, which could make the trust attractive to investors seeking sector exposure and regular income.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
12.99
Dividend Yield
3.18%
Revenue TTM
113.08M
Revenue Per Share
2.83
Gross Profit TTM
93.03M
Debt / Equity
-
ROE
13.83%
Net Debt
208.30M
ROCE
3.25%
Diluted EPS TTM
1.61

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31
Income before tax 11.60M 21.56M -
Net income 11.60M 21.56M -
Selling general administrative 7.56M 9.46M -
Reconciled depreciation 59.27M 41.84M -
Ebit 18.98M 24.44M -0.00M
Other operating expenses 4.29M 5.41M 5.41M
Interest expense 6.63M 2.24M 0.00M
Interest income 5.76M 1.91M -
Net interest income -0.87M -0.33M -
Total revenue 79.87M 73.33M -
Net income from continuing ops 11.60M 21.56M -
Net income applicable to common shares 11.60M 21.56M -0.00M
Breakdown 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31
Total assets 633.42M 436.69M -
Intangible assets 518.13M 293.66M -
Other current assets 0.47M 0.57M -
Total liab 261.08M 57.71M -
Total stockholder equity 372.34M 378.99M -
Other current liab 9.98M 12.10M -
Common stock 373.58M 401.51M 0.00M
Capital stock 373.58M 374.03M -
Retained earnings -1.24M 4.95M -0.00M
Other liab 0.56M 0.14M -
Other assets 50.38M 50.61M -
Cash 36.69M 61.71M -
Total current liabilities 50.10M 18.97M 0.00M
Net debt 208.30M - -
Other stockholder equity - -27.48M 0.00M
Total current assets 64.90M 92.43M 0.00M
Net tangible assets -145.79M 85.33M -0.00M
Net receivables 27.75M 30.15M -
Accounts payable 5.54M 1.56M 0.00M
Breakdown 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31
Investments -273.67M -372.33M -
Change to liabilities -0.60M 0.62M 0.00M
Total cashflows from investing activities -273.67M -372.33M -372.33M
Net borrowings 201.40M -24.40M -24.40M
Total cash from financing activities 171.17M 342.18M 0.00M
Change to operating activities 1.29M -0.85M -0.85M
Net income 11.60M 21.56M -0.00M
Change in cash -25.03M 61.71M 0.00M
Begin period cash flow 61.71M 0.00M -
End period cash flow 36.69M 61.71M -
Total cash from operating activities 77.47M 91.86M 91.86M
Issuance of capital stock 0.00M 400.00M -
Depreciation 59.27M 41.84M 41.84M
Other cashflows from investing activities 0.83M 1.49M 1.49M
Dividends paid 20.23M 3.68M 3.68M
Change to account receivables 3.77M 27.97M 27.97M
Sale purchase of stock -7.26M -5.48M -
Other cashflows from financing activities -2.74M -24.26M -24.26M
Change to netincome 2.14M 0.72M 0.72M
Capital expenditures 274.50M 324.33M 0.00M
Change in working capital 4.46M 27.74M -
Other non cash items 2.14M 0.80M -
Free cash flow -197.03M -232.46M -

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
DHT-U
DRI Healthcare Trust		 0.91
7.01%		 13.90 5.85 17.89 4.69 0.95 1.94
CURA
Curaleaf Holdings Inc.		 -0.37
2.31%		 15.65 - 138.89 2.57 3.14 2.47
BHC
Bausch Health Companies Inc		 0.09
1.13%		 8.06 13.98 1.35 0.28 18.74 2.12
CRON
Cronos Group Inc		 0.04
0.85%		 4.74 - 32.15 9.80 0.95 1.47
TLRY
Tilray Inc		 0.07
1.22%		 5.83 - 1000.00 1.28 0.53 1.08

Profile*

DRI Healthcare Trust

DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.

1 First Canadian Place, Toronto, ON, Canada, M5X 1B1

416 863 1865

https://www.dricapital.com

Name Title Year Born
Mr. Behzad Khosrowshahi CPA CEO & Trustee of DRI Capital Inc. NA
Mr. Chris Anastasopoulos CPA Exec. VP & CFO of DRI Capital Inc. NA
Mr. Stewart Michael Busbridge Exec. VP & COO of DRI Capital Inc. NA
Mr. Navin Cyriac Jacob Exec. VP, Head of Investments & Research - DRI Capital Inc. NA
Ms. Rhizza Marbella VP of Corp. Accounting, Fin. & Investor Relations of DRI Capital Inc NA
Mr. David Levine Director of Investor Relations NA
Ms. Faith Bowen Chief Compliance Officer of DRI Capital Inc. NA
Ms. Gurminder Chahal VP of HR - DRI Capital Inc. NA
Dr. John McCulloch Ph.D. Managing Director of DRI Capital Inc NA
Mr. Babak Farahmand Sr. VP of Asset Operations & Analytics - DRI Capital Inc. NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

GQC
CAD 0.85
+23.19%
DHT-U
CAD 13.90
+7.01%
ACQ
CAD 22.98
+6.78%
IE
CAD 14.79
+5.95%
SGD
CAD 17.50
+5.68%
SLI
CAD 2.63
-9.00%
FLT
CAD 0.58
-6.45%
SGR-U
CAD 7.56
-6.44%
BB
CAD 11.57
-5.71%
SGR-UN
CAD 10.75
-5.70%

Equity Sectors*

  • Basic Materials

    +0.57%

  • Communication Services

    -1.04%

  • Consumer Cyclical

    +1.42%

  • Consumer Defensive

    +0.27%

  • Energy

    -0.96%

  • Financial Services

    +0.26%

  • Healthcare

    +0.72%

  • Industrials

    +0.43%

  • Real Estate

    +0.40%

  • Technology

    -0.33%

  • Utilities

    -0.39%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…